🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Does intensified hormone treatment for #prostatecancer drive increased prevalence of AR alterations? New STAMPEDE analysis in JAMA Oncology, led by Francesca Demichelis and AttardLab at UCL Cancer Institute addresses this important question. Grab a ☕ and read: doi.org/10.1001/jamaon…

The team behind STAMPEDE has been shortlisted for a prestigious NIHR Impact Prize. The trial, which Christie researchers have been involved in, has produced multiple practice-changing results and improved life expectancy for patients with advanced prostate cancer.

Latest edition of our newsletter for GPs and professionals in general practice now available on our website: bit.ly/4iKeyQh #ProstateCancer #Cancer #GeneralPractice #PrimaryCare #Genomics #GenomicMedicine

Fantastic news #NIHRImpactPrize recognising the impact of the #STAMPEDE trial for patients with advanced prostate cancer! Nick James also on @Prof-Nick-James.bsky.social MRC Clinical Trials Unit at UCL AttardLab GU Cancer Research group Manchester Cancer Research Centre The Christie NHS

Abiraterone has been shown to reduce the rate of #ProstateCancer progression and can prevent hundreds of avoidable deaths every year. Yet in England and Northern Ireland, the drug is still not available to men whose lives could be saved. ➡️ Read more: bit.ly/3Y3wCg3

It has begun! 🚀 Day 1 of #EAU25 is in full swing — packed rooms and eager minds ready to absorb the latest in urology! Big congratulations to our YAU member Laura Elst for winning the Best Abstract 2025 at the YAU Meeting! 🏆 Well deserved! Congratulation! #YAU #EAU25

Congrats Aishwarya Kaur & @niroshansa64486. 3️⃣ posters & contributions to 🏆poster- Laura Elst 🔹Sentimag SNB- feasible, efficient, accessible 🔹Thrombosis ⬆️ ILND & TP. Varying prophylaxis amongst expert centres PeCaN GU Cancer Research group The Christie NHS #EAU25 #penilecancer

Trial CI Bryant_Lab delighted to read out #TRANSLATE_Trial results during #GameChanger session European Association of Urology (EAU) #EAU25 Thank you to all our investigators, recruiting sites, funders National Institute for Health and Care Research and, most importantly, our 1126 pts! thelancet.com/journals/lanon… Trial visual abstract below ⬇️

Cheap and easily available Metformin showing great results in mets prostate cancer patients. Important metabolic side effects to be considered from long term ADT Ashwin Sachdeva #EAU2025

Identification of at-risk prostate cancer patients using Fourier transform infrared spectroscopy and machine learning. SPIE: Toward Real-Time Spectroscopic Imaging and Diagnosis; 1331103 (2025) doi.org/10.1117/12.304… Presentation + paper #infrared #prostatecancer #cancer #oa

Exciting to see results of @NeuroSAFEproof presented by Greg Shaw in #GameChanger session European Association of Urology (EAU) #EAU25 So good to have #RCTs in surgical practice - previously lacking for #nervespare as Roderick van den Bergh highlighted Synchronous publication The Lancet Oncology 👏 thelancet.com/journals/lanon…

In the BALANCE trial, patients with bacteremia were assigned to 7 or 14 days of appropriate antimicrobial therapy, and 7 days of therapy was found to be noninferior to 14 days. Full trial results and Research Summary: nej.md/3Z5bTJD

What a weekend for our research group at #EAU25 in Madrid! 🇪🇸 Grateful for the opportunity to share our work across prostate and penile cancers — and proud of the recognition it received! A quick roundup of our team’s highlights 👇

Can quantum cascade laser microscopy acquire #prostatecancer data that's good enough and quick enough for diagnostic lab timeframes? Dougal Ferguson and Peter Gardner at UoM Photon Science share their exciting new findings in Royal Society of Chemistry. Grab a ☕and read: doi.org/10.1039/D5AN00…

[1/7] Let’s take a closer look at the new data on quantum cascade laser (QCL) microscopy in #ProstateCancer, published this week by Dougal Ferguson, Ashwin Sachdeva, Peter Gardner and the team The University of Manchester. 🧵

Our partnership with Dr. Glaucomflecken continues as he summarizes new research into fracture prevention with infrequent zoledronate in women 50 to 60 years of age. Access the article for free: nej.md/DrG15

🚨Can the transcriptome reveal therapeutic vulnerabilities in localized #prostatecancer?🚨 👉Check out our analysis of >140k tumor samples in European Urology Oncology 🔗shorturl.at/k0J3H

Great work, Cameron Alexander & colleagues at BURST Urology!

🚨We’re hiring The Christie NHS! Great opportunity for a motivated clinician to join us as a Clinical Research Fellow in Urology! 🏥 Gain hands-on experience in tertiary surgical uro-oncology 🔬 Contribute to impactful research in prostate cancer ✍️ healthjobsuk.com/job/v7230918

Deadline today! ⏰